PHM
68
4
NI
72
9
SLG
59
6
APD
60
5
ROST
68
-2
RSG
65
5
ADSK
44
8
ALLE
30
5
WFC
60
2
VZ
35
3
HSY
54
4
ROP
65
2
BSX
77
10
ADBE
37
4
ILMN
22
4
FLR
50
2
VTR
69
5
PSX
40
6
CHD
62
8
CHK
23
4
PHM
68
4
NI
72
9
SLG
59
6
APD
60
5
ROST
68
-2
RSG
65
5
ADSK
44
8
ALLE
30
5
WFC
60
2
VZ
35
3
HSY
54
4
ROP
65
2
BSX
77
10
ADBE
37
4
ILMN
22
4
FLR
50
2
VTR
69
5
PSX
40
6
CHD
62
8
CHK
23
4
Financhill
Back

Phathom Pharmaceuticals Vs. Viking Therapeutics Industry Stock Comparison

Buy
57

PHAT
Phathom Pharmaceuticals

Last Price:
9.42
Seasonality Move:
4.67%
Buy
53

VKTX
Viking Therapeutics

Last Price:
62.28
Seasonality Move:
10.92%
Buy
57
Phathom Pharmaceuticals (PHAT) is a Buy

Is Phathom Pharmaceuticals a Buy, Sell or Hold?

  • The current Phathom Pharmaceuticals [PHAT] share price is $9.42. The Score for PHAT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Viking Therapeutics (VKTX) is a Buy

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $62.30. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PHAT Stock Price Chart

What is Phathom Pharmaceuticals's stock price today?

  • The Phathom Pharmaceuticals share price today is $9.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $62.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

PHAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 41.2 Sell
Chaikin Money Flow: -571209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.54 - 10.6) Sell
Bollinger Bands (100): (7.71 - 10.63) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.68 Sell
Relative Strength Index (14 RSI): 39.56 Sell
Chaikin Money Flow: -369406 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (64.67 - 77.83) Sell
Bollinger Bands (100): (34.63 - 80.19) Buy

PHAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.23 Sell
20-day SMA: 10.26 Sell
50-day SMA: 10.14 Sell
200-day SMA: 9.61 Sell
8-day EMA: 10.1 Sell
20-day EMA: 10.14 Sell
50-day EMA: 9.91 Sell
200-day EMA: 9.8 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.1 Sell
20-day SMA: 69.99 Sell
50-day SMA: 71.49 Sell
200-day SMA: 35.49 Buy
8-day EMA: 64.06 Sell
20-day EMA: 67.39 Sell
50-day EMA: 67.06 Sell
200-day EMA: 44.16 Buy

Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

Phathom Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):